Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test

Lancet. 2005 Aug;366(9484):486-7. doi: 10.1016/S0140-6736(05)66793-1.

Abstract

The resurgence of human African trypanosomiasis (HAT), coupled with an increased incidence of drug resistance, is of concern. We report a quick, simple, and sensitive test for identification of parasites resistant to melarsoprol, the main drug used to treat late stage HAT. Resistant parasites are defective in a plasma membrane transporter responsible for drug uptake. The same transporter carries the fluorescent diamidine DB99 (2,5-bis-(4-amidinophenyl)-3,4-dimethylfuran) into trypanosomes. The two DNA-containing structures in the trypanosome--the nucleus and the kinetoplast--begin to fluoresce within 1 min of introduction of DB99, unless drug resistant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arsenicals / pharmacology
  • Diamide
  • Drug Resistance*
  • Fluorescence
  • Melarsoprol / pharmacology*
  • Mice
  • Mice, Inbred ICR
  • Microbial Sensitivity Tests / methods
  • Nucleoside Transport Proteins / metabolism
  • Trypanocidal Agents / pharmacology*
  • Trypanosoma brucei brucei / drug effects*
  • Trypanosoma brucei brucei / metabolism

Substances

  • Arsenicals
  • Nucleoside Transport Proteins
  • P2 transporter, Trypanosoma brucei
  • Trypanocidal Agents
  • Diamide
  • melaminylthioarsenate
  • Melarsoprol